Cargando…
TTYH3 Modulates Bladder Cancer Proliferation and Metastasis via FGFR1/H-Ras/A-Raf/MEK/ERK Pathway
Tweety family member 3 (TTYH3) is a calcium-activated chloride channel with a non-pore-forming structure that controls cell volume and signal transduction. We investigated the role of TTYH3 as a cancer-promoting factor in bladder cancer. The mRNA expression of TTYH3 in bladder cancer patients was in...
Autores principales: | Biswas, Polash Kumar, Kwak, Yeonjoo, Kim, Aram, Seok, Jaekwon, Kwak, Hee Jeong, Lee, Moonjung, Dayem, Ahmed Abdal, Song, Kwonwoo, Park, Jae-Yong, Park, Kyoung Sik, Shin, Hyun Jin, Cho, Ssang-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501546/ https://www.ncbi.nlm.nih.gov/pubmed/36142409 http://dx.doi.org/10.3390/ijms231810496 |
Ejemplares similares
-
Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
por: Seok, Jaekwon, et al.
Publicado: (2023) -
High Expression of TTYH3 Is Related to Poor Clinical Outcomes in Human Gastric Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019) -
New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome
por: Dayem, Ahmed Abdal, et al.
Publicado: (2022) -
Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)